| Literature DB >> 31251774 |
Marie-Claire Parriault1, Amandine Chaponnay2, Claire Cropet1, Vincent About3, Agathe Pastre3, Roch Perusseau-Lambert4, Mathieu Nacher1,2,5, Florence Huber2,6.
Abstract
BACKGROUND: Prisoners in French Guiana, a French territory located in South America, have a HIV and hepatitis B prevalence of 4%. Body modifications such as penile implants, tattoos, and body piercings are common among detainees, increasing the risk of blood-borne virus transmission.Entities:
Mesh:
Year: 2019 PMID: 31251774 PMCID: PMC6599133 DOI: 10.1371/journal.pone.0218992
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Recruitment of male inmates.
Inmates’ sociodemographic characteristics.
| Number | % | |
|---|---|---|
| 18–24 | 57 | 25.8 |
| 25–34 | 84 | 38.0 |
| 35–44 | 43 | 19.5 |
| 45 and more | 37 | 16.7 |
| France | 89 | 40.4 |
| Suriname | 43 | 19.6 |
| Brazil | 29 | 13.2 |
| Guyana | 40 | 18.2 |
| Other | 19 | 8.6 |
| Age when school was interrupted (n = 207) | ||
| Mean | 16.8 (+/- 3.3) | |
| Min : 8 | Max : 29 | |
| Yes | 128 | 58.7 |
| No | 90 | 41.3 |
| 0–11 months | 70 | 32.1 |
| 12–35 months | 76 | 34.9 |
| 36 months and more | 72 | 33.0 |
| First incarceration | 115 | 52.0 |
| One or two past incarcerations | 58 | 26.3 |
| Three past incarcerations and more | 48 | 21.7 |
*14 inmates had never been to school
Fig 2Short-term complication (infectious paraphimosis), following a penile implant insertion, in the French Guiana correctional facility.
Bivariate analysis regarding penile implants inserted during incarceration.
| Penile implants inserted during incarceration | ||
|---|---|---|
| Crude prevalence ratios (95%CI) | ||
| 18–24 | 1 | |
| 25–34 | 1.086 (0.840–1.402) | |
| 35–44 | 0.946 (0.682–1.131) | |
| 45 and more | 0.484 (0.283–0.829) | |
| France | 1 | |
| Surinam | 1.034 (0.767–1.396) | |
| Brazil | 0.708 (0.443–1.131) | |
| Guyana | 1.241 (0.957–1.609) | |
| Other | 0.630 (0.341–1.167) | |
| Has a degree | 0.861 (0.680–1.091) | |
| Does not have any degree | 1 | |
| Yes | 0.854 (0.679–1.074) | |
| No | 1 | |
| Yes | 1.200 (0.933–1.543) | |
| No | 1 | |
| Yes | 1.095 (0.863–1.389) | |
| No | 1 | |
| Yes | 0.575 (0.324–1.019) | |
| No | 1 | |
| Positive | 1.526 (1.180–1.973) | |
| Negative | 1 | |
| Yes | 2.194 (1.601–3.007) | |
| No | 1 | |
| Score < = 4 | 1 | |
| Score >4 | 0.765 (0.600–0.976) | |
| < = median | 1.320 (1.029–1.694) | |
| >median | 1 | |
| 0–11 months | 1 | |
| 12–35 months | 1.412 (1.019–1.958) | |
| 36 months and more | 1.555 (1.133–2.135) | |
| First incarceration | 1 | |
| One or two past incarcerations | 1.570 (1.179–2.090) | |
| Three and more past incarcerations | 2.046 (1.600–2.617) | |
| Yes | 1.717 (1.428–2.064) | |
| No | 1 | |
| Less than 3 | 1 | |
| 3 or more | 0.825 (0.648–1.050) | |
Bold values are significant<0.20
* 4 is the median score. The score ranges from 0 to 8 and is not externally validated
** 3 is the average number of persons per cell
Bivariate analysis regarding declared complications after inlaying penile implant.
| With declared a complication | ||
|---|---|---|
| Crude prevalence ratios (95%CI) | ||
| 18–24 | 1 | |
| 25–34 | 0.540 (0.229–1.269) | |
| 35–44 | 0.755 (0.287–1.988) | |
| 45 and more | 0.343 (0.048–2.435) | |
| France | 1 | |
| Surinam | 1.471 (0.568–3.808) | |
| Brazil | 1.062 (0.256–4.404) | |
| Guyana | 1.319 (0.505–3.442) | |
| Other | 0.911 (0.132–6.278) | |
| Has a degree | 1.714 (0.819–3.588) | |
| Does not have any degree | 1 | |
| Yes | 0.809 (0.378–1.728) | |
| No | 1 | |
| Yes | 1.036 (0.462–2.322) | |
| No | 1 | |
| Yes | 1.948 (0.939–4.040) | |
| No | 1 | |
| Yes | 1.825 (0.522–6.377) | |
| No | 1 | |
| Positive | 1.780 (0.715–4.529) | |
| Negative | 1 | |
| Yes | 0.847 (0.370–1.955) | |
| No | 1 | |
| Score < = 4 | 1 | |
| Score > 4 | 1.080 (0.506–2.307) | |
| < = median | 1.184 (0.526–2.666) | |
| >median | 1 | |
| 0–11 months | 1 | |
| 12–35 months | 0.810 (0.338–1.945) | |
| 36 months and more | 0.604 (0.245–1.554) | |
| First incarceration | 1 | |
| One or two past incarcerations | 0.908 (0.381–2.165) | |
| Three and more past incarcerations | 0.702 (0.278–1.773) | |
| Yes | 1.413 (0.647–3.084) | |
| No | 1 | |
| < 3 | 1 | |
| > = 3 | 1.383 (0.647–2.958) | |
| < 10 | 1 | |
| > = 10 | 1.868 (0.893–3.907) | |
| Razor blade | 1 | |
| Sharp lid of canned food | 1.909 (0.284–12.845) | |
| Other | 1.667 (0.125–22.232) | |
| Yes | 1 | |
| No | 1.116 (0.423–2.945) | |
Bold values are significant<0.20
* 4 is the median score. The score ranges from 0 to 8 and is not externally validated
** 3 is the average number of persons per cell
Predictive factors for penile implants insertion in French Guiana’s correctional facility (CF).
| Inserting penile implants in CF/total (%) | Crude prevalence ratios (95% CI) | Adjusted prevalence ratios (95% CI) | ||
|---|---|---|---|---|
| N = 209 | ||||
| First incarceration | 48/115 (41.7) | 1 | 1 | |
| One or two past incarcerations | 38/58 (65.5) | 1.570 (1.179–2.090) | 1.355 (1.029–1.786) | |
| Three and more past incarcerations | 41/48 (85.4) | 2.046 (1.600–2.617) | 1.491 (1.153–1.927) | |
| Yes | 98/134 (73.1) | 2.194 (1.601–3.007) | 1.737 (1.269–2.378) | |
| No | 29/87 (33.3) | 1 | 1 | |
| Yes | 8/23 (34.8) | 0.575 (0.324–1.019) | 0.639 (0.416–0.983) | |
| No | 115/190 (60.5) | 1 | 1 | |
| Positive | 85/126 (67.5) | 1.526 (1.180–1.973) | 1.326 (1.043–1.687) | |
| Negative | 42/95 (44.2) | 1 | 1 | |
| < = 14 years | 83/130 (63.8) | 1.320 (1.029–1.694) | 1.298 (1.029–1.637) | |
| >14 years | 44/91 (48.3) | 1 | 1 | |
| Score < = 4 | 80/125 (64.0) | 1 | 1 | |
| Score > 4 | 47/96 (48.9) | 0.765 (0.600–0.976) | 0.757 (0.612–0.938) | |
| Yes | 36/41 (87.8) | 1.717 (1.428–2.064) | 1.222 (0.996–1.501) | |
| No | 90/176 (51.1) | 1 | 1 |
Note: Variance inflation factors values do not indicate collinearity between variables
No significant factors were associated with short term local complications in the related multivariate model
* 14 years is the median age
** 4 is the median score
*** p-values for the adjusted prevalence ratios
Comparisons between cross-sectional studies of penile nodules in prison.
| Total male prisoners surveyed | Prisoners with penile implants | Prisoners with penile implants inserted while in prison | ||||
|---|---|---|---|---|---|---|
| n | n | % | n | % | % of total surveyed | |
| French Guiana prison study | 221 | 149 | 67.4% | 127 | 85.2% | 57.5% |
| French Guiana newly incarcerated study (Nacher et al., 2018) | 492 | 145 | 29.6% | N/A | N/A | N/A |
| Australian prisoners study (Yap et al., 2013) | 2018 | 118 | 5.8% | 87 | 73.7% | 4.3% |
Fig 3Short-term complication (infectious paraphimosis), following a penile implant insertion, in French Guiana’s correctional facility.
Fig 4Long-term sequella, 6 months after an infectious paraphimosis following a penile implant insertion (same person than Fig 3).